Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1149387

	registered interest
	date	15/10/2019
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Workplace Pensions: Makerfield
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, how many and what proportion of people in Makerfield constituency have (a) opted out after being auto-enrolled into a workplace pension and (b) saved more than the auto-enrolment minimum contribution.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	602
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>Automatic enrolment has achieved a quiet revolution through getting employees into the habit of pension saving, and reversing the decline in workplace pension participation in the decade prior to these reforms. Since automatic enrolment started in 2012 participation rates have been transformed with 87% of eligible employees saving into a workplace pension in 2018, up from 55% in 2012.</p><p> </p><p>The Department does not hold data for individual constituencies in relation to opt outs or the number of individuals who have saved above the automatic enrolment minimum contribution level. However, we do know that overall around 9% of automatically enrolled workers have chosen to opt out which is significantly below original estimates; and our latest evaluation report shows that, in April 2017, approximately 5.9 million eligible employees were already meeting the April 2019 minimum contribution rates<sup>1</sup>.</p><p> </p><p>I am providing the following information about the impact of automatic enrolment in your constituency, as at end of September 2019<sup>2</sup>:</p><p> </p><p>In the Makerfield constituency since 2012, approximately 5,000 eligible jobholders have been automatically enrolled and 1200 employers have met their duties.</p><p> </p><p><sup>1</sup>Automatic Enrolment Evaluation Report 2018, available via the following weblink: <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/764964/Automatic_Enrolment_Evaluation_Report_2018.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/764964/Automatic_Enrolment_Evaluation_Report_2018.pdf</a>.</p><p> </p><p><sup>2</sup>The Pensions Regulator’s data on Automatic enrolment declaration of compliance by constituency, available via the following weblink:</p><p><a href="https://www.thepensionsregulator.gov.uk/en/document-library/research-and-analysis/data-requests" target="_blank">https://www.thepensionsregulator.gov.uk/en/document-library/research-and-analysis/data-requests</a></p> answering member constituency Hexham answering member printed Guy Opperman question first answered 21/10/2019 11:38:48 answering member 4142 label Biography information for Guy Opperman
	tabling member	4034 label Biography information for Yvonne Fovargue

1584996

	registered interest
	date	07/02/2023
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Unemployment: Insomnia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, what assessment he has made of the potential impact of insomnia on the likelihood of people not being in employment or training.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	141450
	answer	answer is ministerial correction date of answer 15/02/2023 answer text <p>No assessment has been made. However, the Government has funded an extension of the Midlands’ Mental Health and Productivity Pilot, which is trialling interventions, including one with a focus on insomnia, to support and improve employee mental health and wellbeing, to support employees to remain in work. The final evaluation will be available by Spring 2024.</p><p> </p><p>In addition, a range of Government initiatives are supporting disabled people, and people with health conditions, including insomnia, to start, stay, and succeed in, work. These include:</p><p> </p><ul><li>Increasing Work Coach support in Jobcentres for people with health conditions receiving Universal Credit or Employment and Support Allowance;</li><li>Disability Employment Advisers in Jobcentres offering advice and expertise on how to help disabled people and people with health conditions into work;</li><li>The Work and Health Programme and Intensive Personalised Employment Support, providing tailored and personalised support for participants;</li><li>Access to Work grants towards the extra costs of working beyond standard reasonable adjustments;</li><li>Disability Confident, encouraging employers to think differently about disability and health, and to take positive action to address the issues employees face in the workplace;</li><li>The Information and Advice Service, providing better integrated and tailored guidance on supporting and managing health and disability in the workplace; and</li><li>Support in partnership between the DWP and the health system, including Employment Advice in NHS Talking Therapies, which combines psychological treatment and employment support for people with mental health conditions.</li></ul> answering member constituency Corby answering member printed Tom Pursglove question first answered 15/02/2023 12:06:58 answering member 4369 label Biography information for Tom Pursglove
	tabling member	4034 label Biography information for Yvonne Fovargue

1469043

	registered interest
	date	09/06/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Steroid Drugs: Prescriptions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to encourage primary care clinicians to monitor potential over-prescribing of oral corticosteroids.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	15244
	answer	answer is ministerial correction date of answer 07/07/2022 answer text <p>While the National Institute of Health and Care Excellence’s (NICE) guideline ‘Asthma: diagnosis, monitoring and chronic asthma management’ does not specifically make recommendations on oral corticosteroids, NICE is working with the British Thoracic Society and the Scottish Intercollegiate Guidelines Network to produce United Kingdom-wide guidance to update and replace this guideline. Evidence on pharmacological management, including the use of oral corticosteroids, will be reviewed during this process.</p><p>The 2022/23 Quality and Outcomes Framework incentivises general practitioners to assess asthma control through a questionnaire, which records of the number of exacerbations, an assessment of inhaler technique and a written personalised action plan, to monitor potential over-prescribing. The Impact and Investment Fund currently contains two indicators which aim to improve the care of people with asthma, including recognising Primary Care Networks which reduce in the percentage of patients receiving six or more Short-Acting Beta Agonists (SABAs) prescriptions per year.</p><p>NICE’s guidelines for asthma and its guideline ‘Chronic obstructive pulmonary disease in over 16s: diagnosis and management’ recommend oral corticosteroids and alternatives. For adults with asthma, these include SABAs, leukotriene receptor antagonists and long-acting beta2 agonists. For chronic obstructive pulmonary disease (COPD), NICE recommends smoking cessation, SABAs and short-acting muscarinic antagonists, Theophylline tablets, oral mucolytic therapy, oral anti-oxidant therapy, oral anti-tussive therapy, oral prophylactic antibiotic therapy, long-term oxygen therapy, ambulatory oxygen therapy, short-burst oxygen therapy, non-invasive ventilation and pulmonary rehabilitation. NICE has also published technology appraisal guidance on biologics for those with severe asthma, such as Omalizumab for treating severe persistent allergic asthma.</p><p>No specific assessment has been made of the cost of caring for and treating adverse events in patients prescribed frequent or maintenance prescriptions of oral corticosteroids. However, in developing its guidelines, NICE has recommended a number of medicines for patients with severe asthma, such as mepolizumab, which considered the costs and benefits relating to a potential reduction in the use of corticosteroids.</p><p>NHS England and NHS Improvement’s Severe Asthma Collaborative is developing capacity in severe asthma centres to streamline patient pathways to biologic therapies and reduce variation in prescribing and patient management. A toolkit has been produced to support clinical teams.</p><p>The Royal College of General Practitioners’ guidance on long term condition recovery asks clinicians to consider all high-risk patients with COPD and asthma who have not received a review for more than 12 months and have been prescribed either three or more SABAs in the last 12 months; those aged five years old and over not on the asthma or COPD register who have received two or more courses of oral steroids in 12 months; and those on the asthma or COPD register to be prioritised for review.</p><p> </p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 15243 15245 15260 15263 question first answered 07/07/2022 16:26:15 answering member 4680 label Biography information for Gillian Keegan
	tabling member	4034 label Biography information for Yvonne Fovargue

1332080

	registered interest
	date	10/06/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Steroid Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to make recurrent oral corticosteroid use a trigger for treatment reviews in asthma and other conditions.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	13923
	answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>NHS England and NHS Improvement are considering the feasibility of introducing system incentives to increase appropriate prescribing of inhaled corticosteroid inhalers and to improve the prescribing of short-acting beta-agonists inhalers. The aim will be to improve patient outcomes but also reduce carbon emissions.</p><p>An update to the General Practitioner Contract for 2020/21 to 2023/24 includes an improved Quality Outcome Framework asthma domain. This incorporates aspects of care positively associated with better patient outcomes and asthma control, including a review of inhaler technique and record of exacerbations.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 13924 13927 question first answered 18/06/2021 09:40:33 answering member 4380 label Biography information for Jo Churchill
	tabling member	4034 label Biography information for Yvonne Fovargue

1419854

	registered interest
	date	04/02/2022
	answering body	Department for Digital, Culture, Media and Sport
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	hansard heading	Smart Devices: Electronic Commerce
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether smart products sold on online marketplaces will be subject to the provisions of the Product Security and Telecommunications Infrastructure Bill.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	118527
	answer	answer is ministerial correction date of answer 09/02/2022 answer text <p>Security requirements to be set out using the powers in the Product Security and Telecommunications Infrastructure Bill will have to be complied with relation to all relevant consumer connectable products sold to customers in the UK, including those sold on online marketplaces.</p> answering member constituency Hornchurch and Upminster answering member printed Julia Lopez question first answered 09/02/2022 14:02:47 answering member 4647 label Biography information for Julia Lopez
	tabling member	4034 label Biography information for Yvonne Fovargue

1419855

	registered interest
	date	04/02/2022
	answering body	Department for Digital, Culture, Media and Sport
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	hansard heading	Smart Devices
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether she plans to include provisions for when a smart product is recalled within the Product Security and Telecommunications Infrastructure Bill.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	118528
	answer	answer is ministerial correction date of answer 09/02/2022 answer text <p>The Product Security and Telecommunications Infrastructure Bill includes provisions that allow the Secretary of State to issue recall notices relating to relevant insecure consumer connected products, if deemed appropriate.</p> answering member constituency Hornchurch and Upminster answering member printed Julia Lopez question first answered 09/02/2022 14:04:25 answering member 4647 label Biography information for Julia Lopez
	tabling member	4034 label Biography information for Yvonne Fovargue

1487017

	registered interest
	date	06/07/2022
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Silicosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, whether she plans to make silicosis a notifiable disease under the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	31817
	answer	answer is ministerial correction date of answer 12/07/2022 answer text <p>The Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013 (RIDDOR) are made under the Health and Safety at Work etc. Act 1974 and apply to all sectors and workplaces in Great Britain.</p><p> </p><p>The 2013 regulations clarified and simplified the list of reportable ill-health conditions (occupational diseases), as a result of a recommendation made by Professor Löfstedt in his report “<a href="https://www.gov.uk/government/publications/reclaiming-health-and-safety-for-all-lofstedt-report" target="_blank">Reclaiming health and safety for all: An independent review of health and safety legislation</a>,” published in 2011.</p><p> </p><p>The Health and Safety Executive (HSE) keeps the regulations, including specified injuries and reportable diseases, under review. The list of current reportable occupational diseases, including silicosis, will be considered as part of the next formal post-implementation review of RIDDOR, which is due to report in October 2023. HSE will engage with a range of stakeholders as part of the review process.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 12/07/2022 12:05:42 answering member 1609 label Biography information for Chloe Smith
	tabling member	4034 label Biography information for Yvonne Fovargue

1487022

	registered interest
	date	06/07/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Silica: Urban Areas
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what measures he has put in place to (a) assess and (b) control the release of silica dust into urban areas; and what steps he is taking to lower the risk of exposure to that dust among the general public.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	31822
	answer	answer is ministerial correction date of answer 14/07/2022 answer text <p>This is not a matter for the Department for Business, Energy and Industrial Strategy.</p> answering member constituency Loughborough answering member printed Jane Hunt question first answered 14/07/2022 16:05:18 answering member 4839 label Biography information for Jane Hunt
	tabling member	4034 label Biography information for Yvonne Fovargue

1487016

	registered interest
	date	06/07/2022
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Silica: Health and Safety
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, what steps she has taken to help reduce exposure to respirable crystalline silica in the workplace.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	31816
	answer	answer is ministerial correction date of answer 12/07/2022 answer text <p>The Health and Safety Executive (HSE) has a well-established regulatory framework in place to protect workers from the health risks associated with exposure to hazardous substances at work.</p><p> </p><p>Under the <a href="https://www.legislation.gov.uk/uksi/2002/2677/introduction/made" target="_blank">Control of Substances Hazardous to Health Regulations 2002 (COSHH)</a> employers have a duty to prevent or adequately control worker exposure to hazardous substances such as Respirable Crystalline Silica (RCS). COSHH sets out the hierarchy of control that must be implemented and, if managed appropriately, should result in achieving a level below the Work Exposure Limit (WEL) as detailed in HSE Guidance ‘<a href="https://www.hse.gov.uk/pubns/books/eh40.htm" target="_blank">EH40/2005, Workplace exposure limits</a>’.</p><p><br> HSE also delivers communications campaigns to support its regulatory activity. These campaigns inform duty holders and workers of the hazards faced and how these should be controlled and monitored. HSE’s dust campaign which ran in late 2021, included silica exposure, and involved social media and press activity to support awareness of the risks and how to control them.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 12/07/2022 12:08:54 answering member 1609 label Biography information for Chloe Smith
	tabling member	4034 label Biography information for Yvonne Fovargue

1487018

	registered interest
	date	06/07/2022
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Silica: Health and Safety
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, if she will reduce the Workplace Exposure Limit in the UK for silica related work to 0.05 mg/m3 in line with other countries.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	31818
	answer	answer is ministerial correction date of answer 12/07/2022 answer text <p>The Health and Safety Executive (HSE) does not currently intend to review the Workplace Exposure Limit (WEL) of Respirable Crystalline Silica (RCS) in Great Britain. HSE contributed to the more recent European Union (EU) assessment of the limit in January 2019, where the EU reclassified RCS as a carcinogen and implemented the same occupational exposure limit as already existed in GB.</p><p> </p><p>HSE will continue to monitor international developments in this area and the evidence base to consider the range of interventions that might be suitable, including any change to the exposure limit in GB.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 12/07/2022 11:57:39 answering member 1609 label Biography information for Chloe Smith
	tabling member	4034 label Biography information for Yvonne Fovargue